CAR-T Cell Therapy
Revolutionary immunotherapy that reprograms your own immune cells to fight cancer. China offers FDA-approved CAR-T treatments at 60-80% lower cost than the US.
クイック要約
Revolutionary immunotherapy that reprograms your own immune cells to fight cancer. China offers FDA-approved CAR-T treatments at 60-80% lower cost than the US.
費用比較
※ 価格は概算であり、個々のケースにより異なる場合があります。個別のお見積もりについてはお問い合わせください。
対応する症状
治療プロセス
Initial Consultation
3-5 daysSubmit medical records for review by our oncology team
Eligibility Assessment
1-2 weeksComprehensive evaluation to determine CAR-T candidacy
Cell Collection
1 dayLeukapheresis procedure to collect T-cells
CAR-T Manufacturing
2-4 weeksT-cells are engineered in the lab
Conditioning & Infusion
1 weekChemotherapy followed by CAR-T infusion
Monitoring
2-4 weeksClose observation for side effects
よくあるご質問
What is CAR-T cell therapy?
CAR-T (Chimeric Antigen Receptor T-cell) therapy is a type of immunotherapy where your own T-cells are collected, genetically modified to recognize and attack cancer cells, then infused back into your body.
Why is CAR-T cheaper in China?
China has developed its own CAR-T products and manufacturing capabilities, reducing costs significantly. Lower labor costs, government subsidies for biotech, and competitive pricing among hospitals also contribute to savings.
Is CAR-T in China as effective as in the US?
Yes. Chinese CAR-T products have shown comparable efficacy rates in clinical trials. Several Chinese CAR-T therapies have received NMPA approval and are being used in international clinical trials.
What are the risks of CAR-T therapy?
Common side effects include Cytokine Release Syndrome (CRS) and neurological toxicity. Our partner hospitals have experienced teams and protocols to manage these complications effectively.